Navigation Links
Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
Date:9/3/2007

increased likelihood of ADHD in poorer children may include the elevated prevalence of ADHD risk factors (i.e., premature birth and in utero or childhood exposures to toxic substances) in this group, the authors write. In addition, given the high heritability of ADHD and its negative impact on social, academic and career outcomes, it is plausible that families with ADHD may cluster within the lower socioeconomic strata.

Among children meeting criteria for ADHD, 39 percent had received some medication treatment and 32 percent were treated consistently with ADHD medications during the previous year. Despite the prevalence of ADHD in poorer children, they were least likely to receive medications consistently. This finding warrants further investigation and possible intervention to ensure that all children with ADHD have equitable access to treatment when appropriate, the authors conclude.


'/>"/>

Contact: Jim Feuer
513-636-4656
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
4. New Hair in 15 Days Could Now Be A Possibility Say Researchers
5. Researchers at Cornell University as been reported using research fund by false claims
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. Gene researchers make Malaria-resistant mosquito
9. Researchers developed world’s smallest toothbrus
10. Researchers discover receptor cells that can cause epilepsy
11. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... helps companies develop and test their cleaning processes. The technology available ... industries and solve problems for customers relating to cleaning parts, process ... ... -- Midbrook, Inc , a Jackson, MI-based company, is home ...
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... employees came together in more than 90 offices nationwide today, ... audit, tax and advisory firm,s support for literacy with charitable ... long history of volunteerism. Instead of holiday parties, our employees ... for some children," said Tim Flynn, Chairman of KPMG. ...
(Date:12/4/2009)... and Services for the Aging (AAHSA) applauds the Senate for ... provisions remain in the final health reform legislation . The ... with disabilities and their caregivers. ,, We urge the ... make it affordable to care for families and caregivers. , ...
(Date:12/4/2009)... MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and ... Allergan, Inc. (NYSE: AGN ) as ... Inc. (NYSE: BCR ) as its February ... "The committee chose Allergan because of growth opportunities involving its ...
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2
... Will Discuss the Valecor Platinum(TM) Coronary Stent System ... 14 CorNova Inc. today announced S. Eric ... officer, will present the Valecor Platinum(TM) Coronary Stent ... Glimpse into the Future: Emerging Drug-Eluting Stents ...
... Healthcare has launched the free online board, MedicalMissions.org ( http://www.medicalmissions.org ... around the world. The new website is designed for charitable ... volunteer interests and needs. , ... ...
... TODAY, City-wide Rosters to Include Thousands of ... Influential Doctors by Disease Specialty and Location SANTA FE, ... and predictive modeling company, is launching a new quarterly health ... TODAY. The first-of-its-kind online database provides consumers with access to ...
... at the Advanced Fertility Center of Chicago reveals that women with ... not a correspondingly higher rate of success -- with in-vitro fertilization. ... ... Infertility specialist Richard Sherbahn, MD , and embryologist Ellen Gibbons ...
... Management Health Solutions, Inc. (MHS), a leader in the field of ... today an offer of free data cleansing for all hospitals and ... ... (PRWEB) May 14, 2009-- Management Health Solutions, Inc. (MHS), a leader ...
... Launch of C7XR(TM) FD-OCT Imaging System and Companion ... Mass., May 14 LightLab Imaging Inc., the ... Coherence Tomography (OCT) for vascular and other applications, ... the C7XR FD-OCT Imaging System with the C7 ...
Other Medicine News:Health News:Free Medical Mission 'Job Board' Launched 2Health News:Free Medical Mission 'Job Board' Launched 3Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 2Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 4Health News:Management Health Solutions, Inc. Offers Free Data Cleansing 2Health News:Management Health Solutions, Inc. Offers Free Data Cleansing 3Health News:LightLab Imaging Introduces World's Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009 2
(Date:12/4/2009)... (NYSE: WPI ), a leading global specialty ... Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with ... market its 8mg ramelteon tablets prior to the expiration ... Watson,s 8mg ramelteon tablet product is a generic ...
(Date:12/4/2009)... disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), ... comorbidities reported to occur more often in people ... versus those without an epilepsy diagnosis, according to ... U.S. ,, Findings from " CNS-Related Comorbidities in ...
(Date:12/3/2009)... (Nasdaq: PCYC ), a biopharmaceutical company focused on ... treatment of immune mediated diseases and cancer, today announced ... on, Tuesday, December 8, 2009 at 11:00am Eastern Time ... clinical data regarding its HDAC Program (PCI-24781) and its ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 1Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 2Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 3Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 4Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 5Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 6Neurobiological Technologies Partner Celtic Pharma Announces Results of XERECEPT 28R 29 Phase 3 Clinical Program 4501 7Young Ballerinas May Face Heart Bone Risks 47452 1Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 1Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 2Worth of Sigmoidoscopy Screening for Colon Cancer Still Uncertain 47450 3
... Jan. 7 ImQuest Life Sciences announced today the ... and Drug Administration to initiate human clinical trials for ... their Phase 1 studies in the first quarter of ... HIV which primarily acts as a nonnucleoside reverse transcriptase ...
... U.S., U.K. and China TrialsSAN DIEGO, Jan. 7 ... liver disease, today announced patient enrollment has begun for ... will study the Extracorporeal Liver Assist Device (ELAD) as ... under three protocols. The study is open for enrollment ...
Other Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
Medicine Products: